Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Innoviva, Inc. Common Stock (INVA)

Pharmaceutical Preparations

https://www.inva.com

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.

1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/05/2004

Market Cap

1,152,714,063

Shares Outstanding

64,090,000

Weighted SO

64,086,675

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

EFTR --.--%

PLX --.--%

PDSB --.--%

LIFE --.--%

ELEV --.--%

DAWN --.--%

MRTX --.--%

AMLX --.--%

TERN --.--%

Beta

0.5740

Last Div

0.0000

Range

12.22-19.44

Chg

0.0150

Avg Vol

499762

Mkt Cap

1152714063

Exch

NASDAQ

Country

US

Phone

650 238 9600

DCF Diff

-63.2618

DCF

79.4317

Div Yield

0.0000

P/S

3.3820

EV Multiple

7.7507

P/FV

1.7311

Div Yield %

0.0000

P/E

7.9219

PEG

1.1398

Payout

0.0000

Current Ratio

12.7022

Quick Ratio

11.4023

Cash Ratio

7.6935

DSO

100.6417

DIO

184.2920

Op Cycle

284.9336

DPO

10.2491

CCC

274.6845

Gross Margin

0.7870

Op Margin

0.6113

Pretax Margin

0.4489

Net Margin

0.4267

Eff Tax Rate

0.0495

ROA

0.1187

ROE

0.2177

ROCE

0.1741

NI/EBT

0.9505

EBT/EBIT

0.7343

EBIT/Rev

0.6113

Debt Ratio

0.3663

D/E

0.6743

LT Debt/Cap

0.4019

Total Debt/Cap

0.4027

Int Coverage

9.4707

CF/Debt

0.3520

Equity Multi

1.8406

Rec Turnover

3.6267

Pay Turnover

35.6130

Inv Turnover

1.9806

FA Turnover

96.1467

Asset Turnover

0.2783

OCF/Share

2.5264

FCF/Share

2.5203

Cash/Share

3.4706

OCF/Sales

0.4635

FCF/OCF

0.9976

CF Coverage

0.3520

ST Coverage

108.8649

CapEx Coverage

417.8915

Div&CapEx Cov

417.8915

P/BV

1.7311

P/B

1.7311

P/S

3.3820

P/E

7.9219

P/FCF

7.3149

P/OCF

7.2931

P/CF

7.2931

PEG

1.1398

P/S

3.3820

EV Multiple

7.7507

P/FV

1.7311

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.25 09/08/2015 07/30/2015 09/10/2015 09/30/2015
0.25 06/10/2015 05/06/2015 06/12/2015 06/30/2015
0.25 03/10/2015 02/23/2015 03/12/2015 03/31/2015
0.25 11/21/2014 10/16/2014 11/25/2014 12/23/2014
0.25 08/26/2014 08/06/2014 08/28/2014 09/18/2014